rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Allient Inc.

ALNT · Nasdaq

Health CareLife-science toolsLeadingRobotics

ALNT stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 6.6% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+1 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
52 in a row
Industry in uptrend
52% +1 in 4 wk
Insider buys, 12 months
$147K
Insider sales, 12 months
$17.6M
Officials’ trades on record
0
Institutions holding
220 (+16)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.

21 Apr – 20 Oct
27%44%61%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$15.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months5
Buyers · sellers1 · 3
WhoDidSharesTraded
Michael R. WinterDirectorsold457at $109.2723 Sep 2026filed 23 Sep 2026
Michael R. WinterDirectorbought457at $108.9723 Sep 2026filed 23 Sep 2026
Richard S. WarzalaChief Executive Officersold17,028at $112.8110 Aug 2026filed 12 Aug 2026
Richard S. WarzalaChief Executive Officersold18,176at $113.5210 Aug 2026filed 12 Aug 2026
Richard S. WarzalaChief Executive Officersold33,944at $113.9610 Aug 2026filed 12 Aug 2026
Richard S. WarzalaChief Executive Officersold852at $115.3510 Aug 2026filed 12 Aug 2026
Ashish BendreVP and Group Presidentsold6,000at $63.0027 Mar 2026filed 30 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders220+16 on the quarter
New · exited51 · 34
Reported value$1.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCreduced · filed 13 Aug 20262,015,087$207.4M-47,577−2.3%
BlackRock, Inc.added · filed 7 Aug 20261,251,086$128.8M+70,859+6.0%
Juniper Investment Company, LLCreduced · filed 14 Aug 2026762,305$78.5M-33,617−4.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026672,685$69.2M+10,734+1.6%
JENNISON ASSOCIATES LLCadded · filed 3 Aug 2026512,528$52.8M+159,098+45.0%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026505,662$52.0M-99,599−16.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026462,402$47.6M+24,218+5.5%
STATE STREET CORPadded · filed 7 Aug 2026409,102$42.1M+6,662+1.7%
Portolan Capital Management, LLCadded · filed 14 Aug 2026359,685$37.0M+36,232+11.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026306,318$31.5M+61,812+25.3%
31 Mar 2023 – 30 Jun 2026
101159216Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Michael R. Winter Company insiderDirector · last 23 Sep 20265 · 3
Richard S. Warzala Company insiderChief Executive Officer · last 10 Aug 202610 · 29
Nicole R. Tzetzo Company insiderDirector · last 5 Aug 20265 · 0
Richard D. Federico Company insiderDirector · last 5 Aug 202613 · 1
Robert B. Engel Company insiderDirector · last 5 Aug 20263 · 0
Steven C. Finch Company insiderDirector · last 5 Aug 20260 · 0
Ashish Bendre Company insiderVP and Group President · last 6 May 20262 · 3
Helmut Pirthauer Company insiderVP and Group President · last 1 Apr 20260 · 0
James A. Michaud Company insiderChief Financial Officer · last 1 Apr 20260 · 0
Kenneth Arthur May Company insiderChief Technology Officer · last 1 Apr 20260 · 0
Stephen Warzala Company insiderVP and Group President · last 1 Apr 20260 · 0
Geoffery Rondeau Company insiderVP of Operational Excellence · last 13 May 20250 · 1

Same industry

OABI OmniAbLeading+75%
TXG 10x GenomicsLeading+61%
AVTR AvantorLeading+48%
ILMN IlluminaLeading+46%
RVTY RevvityLeading+39%
MASS 908 DevicesLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202532.8%
Operating profit marginFY 2025 · to 31 Dec 20257.9%
Free cash flow marginFY 2025 · to 31 Dec 20259.0%
Return on capital employedFY 2025 · to 31 Dec 20258.7%
Debt to equityFY 2025 · to 31 Dec 20250.60×
Share count trendFY 2025 · to 5 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$40.7M
Free cash flowFY 2025 · to 31 Dec 2025$49.7M

Analyst forecasts

No analyst forecasts yet.